ArticleHaematologica2021

Dual intracellular targeting by ruxolitinib and the Mcl-1 inhibitor S63845 in interleukin-6-dependent myeloma cells blocks

Renate Burger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.